
News|Articles|May 1, 2018
Wyatt Technology Announces Executive Team Changes
Author(s)Pharmaceutical Technology Editors
Geofrey Wyatt has been named CEO and Clifford Wyatt named president of Wyatt Technology.
Advertisement
Wyatt Technology, a developer of instrumentation for absolute macromolecular and nanoparticle characterization, announced changes to its executive team on May 1, 2018.
Geofrey Wyatt was named chief executive office, and Clifford Wyatt was named president. Philip Wyatt, who founded the company almost 40 years ago, will become chairman of the board and take on a more passive role, the company reported in a press statement.
The company also announced that Michelle Chen was promoted to vice-president of analytical services and will join the executive team.
Source:
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
2
Renewing Prosaic Generics for Cancer Treatment
3
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5




